BRAF and thyroid cancer: We found that a fraction of pY397 FAK co-localizes with the nucleolar marker, FBL, in the panel of BRAF- and RAS-mutant thyroid cancer cell lines derived from PTC or ATC tumors (Figure 2A; Supplementary Figure 3).